Advertisement
Screener

SOLIGENIX, INC. (SNGX) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

SOLIGENIX, INC. Operating Expenses

SOLIGENIX, INC. (SNGX) reported Operating Expenses of $2.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-07

  • SOLIGENIX, INC. operating expenses for the quarter ending 2026-06-30 was $2.10M, a 24.04% decline year-over-year.
  • SOLIGENIX, INC. operating expenses for the quarter ending 2026-03-31 was $2.88M, a 4.68% decline year-over-year.
  • SOLIGENIX, INC. operating expenses for the quarter ending 2025-12-31 was $3.47M, a 6.41% decline year-over-year.
  • SOLIGENIX, INC. operating expenses for the quarter ending 2025-09-30 was $2.58M, a 38.35% increase year-over-year.
  • SOLIGENIX, INC. operating expenses for fiscal 2025 was $11.85M, a 25.49% increase from fiscal 2024.
  • SOLIGENIX, INC. operating expenses for fiscal 2024 was $9.44M, a 21.09% increase from fiscal 2023.
  • SOLIGENIX, INC. operating expenses for fiscal 2023 was $7.80M, a 46.74% decline from fiscal 2022.
  • SOLIGENIX, INC. operating expenses for fiscal 2022 was $14.64M, a 10.93% increase from fiscal 2021.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-06-30$2.10M
10-Q · filed 2026-08-07
$4.98M
10-Q · filed 2026-08-07
$8.46M
derived: sum of 3 quarters · filed 2026-08-07
$11.04M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$2.88M
10-Q · filed 2026-05-08
$6.36M
derived: sum of 2 quarters · filed 2026-05-08
$8.94M
derived: sum of 3 quarters · filed 2026-05-08
$11.70M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$3.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$6.06M
derived: sum of 2 quarters · filed 2026-03-31
$8.82M
derived: sum of 3 quarters · filed 2026-08-07
$11.85M
10-K · filed 2026-03-31
2025-09-30$2.58M
10-Q · filed 2025-11-07
$5.34M
derived: sum of 2 quarters · filed 2026-08-07
$8.37M
10-Q · filed 2025-11-07
$12.08M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$2.76M
10-Q · filed 2026-08-07
$5.79M
10-Q · filed 2026-08-07
$9.50M
derived: sum of 3 quarters · filed 2026-08-07
$11.37M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$3.03M
10-Q · filed 2026-05-08
$3.31M
10-Q · filed 2025-05-09
$6.74M
derived: sum of 2 quarters · filed 2026-05-08
$8.60M
derived: sum of 3 quarters · filed 2026-05-08
$10.35M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$3.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$5.58M
derived: sum of 2 quarters · filed 2026-03-31
$7.32M
derived: sum of 3 quarters · filed 2026-03-31
$9.44M
10-K · filed 2026-03-31
2024-09-30$1.87M
10-Q · filed 2025-11-07
$3.61M
derived: sum of 2 quarters · filed 2025-11-07
$5.73M
10-Q · filed 2025-11-07
$7.89M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$1.74M
10-Q · filed 2025-08-14
$3.86M
10-Q · filed 2025-08-14
$6.02M
derived: sum of 3 quarters · filed 2025-08-14
$7.82M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$2.12M
10-Q · filed 2025-05-09
$4.28M
derived: sum of 2 quarters · filed 2025-05-09
$6.08M
derived: sum of 3 quarters · filed 2025-05-09
$7.73M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$2.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
$3.96M
derived: sum of 2 quarters · filed 2025-03-21
$5.61M
derived: sum of 3 quarters · filed 2025-03-21
$7.80M
10-K · filed 2025-03-21
2023-09-30$1.80M
10-Q · filed 2024-11-08
$3.45M
derived: sum of 2 quarters · filed 2024-11-08
$5.63M
10-Q · filed 2024-11-08
$9.43M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$1.65M
10-Q · filed 2024-08-09
$3.84M
10-Q · filed 2024-08-09
$7.64M
derived: sum of 3 quarters · filed 2024-08-09
$10.75M
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$2.18M
10-Q · filed 2024-05-10
$5.98M
derived: sum of 2 quarters · filed 2024-05-10
$9.10M
derived: sum of 3 quarters · filed 2024-05-10
$12.53M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$3.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
$6.92M
derived: sum of 2 quarters · filed 2024-03-15
$10.35M
derived: sum of 3 quarters · filed 2024-03-15
$14.64M
10-K · filed 2024-03-15
2022-09-30$3.12M
10-Q · filed 2023-11-13
$6.55M
derived: sum of 2 quarters · filed 2023-11-13
$10.84M
10-Q · filed 2023-11-13
$15.39M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$3.43M
10-Q · filed 2023-08-21
$7.72M
10-Q · filed 2023-08-21
$12.27M
derived: sum of 3 quarters · filed 2023-08-21
$15.66M
derived: sum of 4 quarters · filed 2023-08-21
2022-03-31$4.29M
10-Q · filed 2023-05-15
$4.30M
10-Q · filed 2022-05-13
$8.84M
derived: sum of 2 quarters · filed 2023-05-15
$12.22M
derived: sum of 3 quarters · filed 2023-05-15
$15.22M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$4.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$7.94M
derived: sum of 2 quarters · filed 2023-03-31
$10.94M
derived: sum of 3 quarters · filed 2023-03-31
$13.19M
10-K · filed 2023-03-31
$13.24M
10-K · filed 2022-03-29
2021-09-30$3.38M
10-Q · filed 2022-11-10
$3.40M
10-Q · filed 2021-11-12
$6.38M
derived: sum of 2 quarters · filed 2022-11-10
$8.64M
10-Q · filed 2022-11-10
$8.67M
10-Q · filed 2021-11-12
$14.21M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$3.00M
10-Q · filed 2022-08-12
$3.02M
10-Q · filed 2021-08-13
$5.26M
10-Q · filed 2022-08-12
$5.28M
10-Q · filed 2021-08-13
$10.82M
derived: sum of 3 quarters · filed 2022-08-12
$12.86M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$2.26M
10-Q · filed 2022-05-13
$7.82M
derived: sum of 2 quarters · filed 2022-05-13
$9.86M
derived: sum of 3 quarters · filed 2022-05-13
$12.82M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$5.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$7.60M
derived: sum of 2 quarters · filed 2022-03-29
$10.56M
derived: sum of 3 quarters · filed 2022-03-29
$19.13M
10-K · filed 2022-03-29
2020-09-30$2.03M
10-Q · filed 2021-11-12
$4.99M
derived: sum of 2 quarters · filed 2021-11-12
$13.56M
10-Q · filed 2021-11-12
$16.97M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$2.96M
10-Q · filed 2021-08-13
$11.52M
10-Q · filed 2021-08-13
$14.93M
derived: sum of 3 quarters · filed 2021-08-13
$17.99M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31$8.57M
10-Q · filed 2021-05-18
$11.98M
derived: sum of 2 quarters · filed 2021-05-18
$15.03M
derived: sum of 3 quarters · filed 2021-05-18
$17.66M
derived: sum of 4 quarters · filed 2021-05-18
2019-12-31$3.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
$6.46M
derived: sum of 2 quarters · filed 2021-03-30
$9.09M
derived: sum of 3 quarters · filed 2021-03-30
$11.60M
10-K · filed 2021-03-30
2019-09-30$3.06M
10-Q · filed 2020-11-12
$5.68M
derived: sum of 2 quarters · filed 2020-11-12
$8.20M
10-Q · filed 2020-11-12
$11.48M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$2.62M
10-Q · filed 2020-08-14
$5.14M
10-Q · filed 2020-08-14
$8.42M
derived: sum of 3 quarters · filed 2020-08-14
$10.49M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$2.52M
10-Q · filed 2020-05-15
$5.80M
derived: sum of 2 quarters · filed 2020-05-15
$7.86M
derived: sum of 3 quarters · filed 2020-05-15
$9.68M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$3.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$5.35M
derived: sum of 2 quarters · filed 2020-03-30
$7.17M
derived: sum of 3 quarters · filed 2020-03-30
$9.70M
10-K · filed 2020-03-30
2018-09-30$2.06M
10-Q · filed 2019-11-12
$3.88M
derived: sum of 2 quarters · filed 2019-11-12
$6.42M
10-Q · filed 2019-11-12
$9.21M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$1.82M
10-Q · filed 2019-08-13
$4.36M
10-Q · filed 2019-08-13
$7.14M
derived: sum of 3 quarters · filed 2019-08-13
$8.46M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31$2.53M
10-Q · filed 2019-05-14
$5.32M
derived: sum of 2 quarters · filed 2019-05-14
$6.64M
derived: sum of 3 quarters · filed 2019-05-14
$9.27M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
$4.10M
derived: sum of 2 quarters · filed 2019-03-26
$6.73M
derived: sum of 3 quarters · filed 2019-03-26
$8.72M
10-K · filed 2019-03-26
2017-09-30$1.32M
10-Q · filed 2018-11-09
$3.95M
derived: sum of 2 quarters · filed 2018-11-09
$5.93M
10-Q · filed 2018-11-09
$7.69M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30$2.63M
10-Q · filed 2018-08-08
$4.61M
10-Q · filed 2018-08-08
$6.38M
derived: sum of 3 quarters · filed 2018-08-08
$8.21M
derived: sum of 4 quarters · filed 2018-08-08
2017-03-31$1.98M
10-Q · filed 2018-05-11
$3.75M
derived: sum of 2 quarters · filed 2018-05-11
$5.57M
derived: sum of 3 quarters · filed 2018-05-11
$7.40M
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31$1.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$3.59M
derived: sum of 2 quarters · filed 2018-03-15
$5.42M
derived: sum of 3 quarters · filed 2018-03-15
$7.72M
10-K · filed 2018-03-15
2016-09-30$1.83M
10-Q · filed 2017-11-06
$3.66M
derived: sum of 2 quarters · filed 2017-11-06
$5.96M
10-Q · filed 2017-11-06
$8.69M
derived: sum of 4 quarters · filed 2017-11-06
2016-06-30$1.83M
10-Q · filed 2017-08-11
$4.13M
10-Q · filed 2017-08-11
$6.86M
derived: sum of 3 quarters · filed 2017-08-11
$8.96M
derived: sum of 4 quarters · filed 2017-08-11
2016-03-31$2.30M
10-Q · filed 2017-05-11
$5.04M
derived: sum of 2 quarters · filed 2017-05-11
$7.14M
derived: sum of 3 quarters · filed 2017-05-11
$9.45M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$2.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27
$4.83M
derived: sum of 2 quarters · filed 2017-03-27
$7.15M
derived: sum of 3 quarters · filed 2017-03-27
$9.00M
10-K · filed 2017-03-27
2015-09-30$2.10M
10-Q · filed 2016-11-10
$4.42M
derived: sum of 2 quarters · filed 2016-11-10
$6.26M
10-Q · filed 2016-11-10
$8.98M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$2.32M
10-Q · filed 2016-08-11
$4.17M
10-Q · filed 2016-08-11
$6.88M
derived: sum of 3 quarters · filed 2016-08-11
$12.70M
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31$1.85M
10-Q · filed 2016-05-12
$4.57M
derived: sum of 2 quarters · filed 2016-05-12
$10.39M
derived: sum of 3 quarters · filed 2016-05-12
$12.47M
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31$2.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24
$8.54M
derived: sum of 2 quarters · filed 2016-03-24
$10.62M
derived: sum of 3 quarters · filed 2016-03-24
$12.49M
10-K · filed 2016-03-24
2014-09-30$5.82M
10-Q · filed 2015-11-12
$7.90M
derived: sum of 2 quarters · filed 2015-11-12
$9.77M
10-Q · filed 2015-11-12
$11.57M
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$2.08M
10-Q · filed 2015-08-12
$3.95M
10-Q · filed 2015-08-12
$5.76M
derived: sum of 3 quarters · filed 2015-08-12
$7.68M
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$1.87M
10-Q · filed 2015-05-14
$3.68M
derived: sum of 2 quarters · filed 2015-05-14
$5.60M
derived: sum of 3 quarters · filed 2015-05-14
$8.46M
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
$3.73M
derived: sum of 2 quarters · filed 2015-03-25
$6.59M
derived: sum of 3 quarters · filed 2015-03-25
$7.84M
10-K · filed 2015-03-25
2013-09-30$1.93M
10-Q · filed 2014-11-10
$4.79M
derived: sum of 2 quarters · filed 2014-11-10
$6.03M
10-Q · filed 2014-11-10
$7.68M
derived: sum of 4 quarters · filed 2014-11-10
2013-06-30$2.86M
10-Q · filed 2014-08-11
$4.10M
10-Q · filed 2014-08-11
$5.76M
derived: sum of 3 quarters · filed 2014-08-11
$6.69M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$1.24M
10-Q · filed 2014-05-12
$2.90M
derived: sum of 2 quarters · filed 2014-05-12
$3.83M
derived: sum of 3 quarters · filed 2014-05-12
$4.95M
derived: sum of 4 quarters · filed 2014-05-12
2012-12-31$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
$2.58M
derived: sum of 2 quarters · filed 2014-03-26
$3.71M
derived: sum of 3 quarters · filed 2014-03-26
$5.24M
10-K · filed 2014-03-26
2012-09-30$930.22K
10-Q · filed 2013-11-12
$2.06M
derived: sum of 2 quarters · filed 2013-11-12
$3.59M
10-Q · filed 2013-11-12
$5.20M
derived: sum of 4 quarters · filed 2013-11-12
2012-06-30$1.13M
10-Q · filed 2013-08-12
$2.66M
10-Q · filed 2013-08-12
$4.27M
derived: sum of 3 quarters · filed 2013-08-12
$7.21M
derived: sum of 4 quarters · filed 2013-08-12
2012-03-31$1.53M
10-Q · filed 2013-05-03
$3.14M
derived: sum of 2 quarters · filed 2013-05-03
$6.08M
derived: sum of 3 quarters · filed 2013-05-03
$8.07M
derived: sum of 4 quarters · filed 2013-05-03
2011-12-31$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$4.55M
derived: sum of 2 quarters · filed 2013-02-26
$6.54M
derived: sum of 3 quarters · filed 2013-02-26
$8.51M
10-K · filed 2013-02-26
2011-09-30$2.94M
10-Q · filed 2012-11-14
$4.93M
derived: sum of 2 quarters · filed 2012-11-14
$6.90M
10-Q · filed 2012-11-14
$9.40M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$1.99M
10-Q · filed 2012-08-10
$3.97M
10-Q · filed 2012-08-10
$6.46M
derived: sum of 3 quarters · filed 2012-08-10
$8.28M
derived: sum of 4 quarters · filed 2012-08-10
2011-03-31$1.98M
10-Q · filed 2012-05-14
$4.47M
derived: sum of 2 quarters · filed 2012-05-14
$6.29M
derived: sum of 3 quarters · filed 2012-05-14
$7.97M
derived: sum of 4 quarters · filed 2012-05-14
2010-12-31$2.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27
$4.31M
derived: sum of 2 quarters · filed 2012-03-27
$5.99M
derived: sum of 3 quarters · filed 2012-03-27
$8.19M
10-K · filed 2012-03-27
2010-09-30$1.82M
10-Q · filed 2011-11-14
$3.50M
derived: sum of 2 quarters · filed 2011-11-14
$5.69M
10-Q · filed 2011-11-14
2010-06-30$1.68M
10-Q · filed 2011-08-12
$3.87M
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Imunon, Inc. (IMNN)United States$0.008B-0.56
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97